Identification by differential display of IL-24 autocrine loop activated by ras oncogenes

Zhongjia Tan1, Mai Wang, Peng Liang

  • 1Department of Cell Biology, Vanderbilt-Ingram Cancer Center, School of Medicine, Vanderbilt University, Nashville, TN, USA.

Insights

Researchers discovered a new cytokine, IL-24, regulated by the Ras signaling pathway. This cytokine and its receptors may form a novel autocrine loop activated by oncogenes, impacting cell growth and differentiation.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • The Ras signaling pathway regulates critical cellular processes like growth and differentiation.
  • Specific Ras target genes involved in these processes remain largely undefined.

Purpose of the Study:

  • To identify novel oncogenic Ras target genes.
  • To characterize a newly identified cytokine and its role in Ras-mediated signaling.

Main Methods:

  • Differential display technique was employed to identify novel genes.
  • Biochemical studies were conducted to characterize the cytokine and its receptor interactions.

Main Results:

  • A novel oncogenic Ras target gene encoding a new cytokine, IL-24, was identified.
  • IL-24 belongs to the IL-10 family of cytokines.
  • IL-24 signals through two heterodimeric receptors, also upregulated by Ras oncogenes.

Conclusions:

  • IL-24 and its receptors represent a novel autocrine loop.
  • This loop is coordinately activated by Ras oncogenes, potentially influencing cell growth and differentiation.

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...